References
R. R. Bartlett and R. Schleyerbach,Immunopharmacological profile of a novel isoxazol derivative HWA 486, with potential antirheumatic activity-I. Disease modifying action on adjuvant arthritis of the rat. Int. J. Immunopharm.7, 7–18 (1985).
R. R. Bartlett,Immunopharmacological profile of HWA 486, a novel isoxazol derivative-II. In vivo immunomodulating effects differ from those of Cyclophosphamide, Prednisolone, or Cyclosporin A. Int. J. Immunopharm.8, 199–204 (1986).
L. M. Hudson and F. Hay,Antibody interaction with antigen, InPractical Immunology. Blackwell Scientific, Oxford 1976.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Popovic, S., Bartlett, R.R. Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice. Agents and Actions 19, 313–314 (1986). https://doi.org/10.1007/BF01971235
Issue Date:
DOI: https://doi.org/10.1007/BF01971235